Intervention Protocol

Botulinum toxin for the treatment of chronic idiopathic constipation

  1. Hong Ling Li1,
  2. Yi Ping Li1,
  3. He Su1,
  4. Xiang Yong Hao1,*,
  5. Yuan Hui Gu1,
  6. Yun Tao Ma1,
  7. Lei Jiang2,
  8. Yuan Li1

Editorial Group: Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group

Published Online: 7 OCT 2009

DOI: 10.1002/14651858.CD008015


How to Cite

Li HL, Li YP, Su H, Hao XY, Gu YH, Ma YT, Jiang L, Li Y. Botulinum toxin for the treatment of chronic idiopathic constipation (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD008015. DOI: 10.1002/14651858.CD008015.

Author Information

  1. 1

    The People's Hospital of Gansu Province, Lanzhou City, Gansu, China

  2. 2

    Lanzhou University, Centre of Evidence Based Medicine, Lanzhou City, Gansu, China

*Xiang Yong Hao, The People's Hospital of Gansu Province, Dong Gang West Road No.160, Lanzhou City, Gansu, 730000, China. haoxy198310@yahoo.com.cn.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.